The Only Monthly Membership With a Positive ROI!
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The Only Monthly Membership With a Positive ROI!
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Mind Medicine
MNMD
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$6.02
0.04
0.75%
At Close: -
$6.04
0.02
0.33%
After Hours: Aug 23, 7:59 PM EDT
15 minutes delayed
Get Report
Comment
Mind Medicine (MNMD) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Mind Medicine (NASDAQ:MNMD) Stock
Mind Medicine Stock (NASDAQ: MNMD)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, August 13, 2024
Mind Medicine Q2 2024 GAAP EPS $(0.26) Beats ...
Benzinga Newsdesk
Monday, August 12, 2024
Psychedelics Company MindMed Prices Public Offering Aiming To Raise $75M
Nina Zdinjak
Friday, August 09, 2024
Mind Medicine shares are trading lower after ...
Benzinga Newsdesk
MindMed Prices Public Offering Of 9.29M Commo...
Benzinga Newsdesk
Mind Medicine (MindMed) Inc. Announces Propos...
Benzinga Newsdesk
Wednesday, July 31, 2024
HC Wainwright & Co. Reiterates Buy on Mind Me...
Benzinga Newsdesk
EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves
Javier Hasse
Wednesday, July 24, 2024
Roth MKM Maintains Buy on Mind Medicine, Main...
Benzinga Newsdesk
Wednesday, July 17, 2024
MindMed Announces PAtent Covering MM120 Orall...
Benzinga Newsdesk
Tuesday, July 16, 2024
'MDMA Therapy Gets Support From Prominent Res...
Benzinga Newsdesk
Monday, July 08, 2024
'California Legislature Approves Bill To Brea...
Benzinga Newsdesk
Friday, June 28, 2024
MindMed To Be Included In Russell 2000 And Ru...
Benzinga Newsdesk
Wednesday, June 26, 2024
Groundbreaking Fentanyl Vaccine Being Developed To Prevent Fatal Overdoses, Startup Secures $10M
Maureen Meehan
Friday, June 21, 2024
Cantor Fitzgerald Reiterates Overweight on Mi...
Benzinga Newsdesk
Thursday, June 20, 2024
MindMed Reports Completion Of End-of-phase 2 ...
Benzinga Newsdesk
Wednesday, June 12, 2024
'Oregon's First-In-Nation Psilocybin Industry...
Benzinga Newsdesk
Wednesday, June 05, 2024
Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment
Aaron Bry
Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
What's Going On With MindMed And Psychedelic Stocks?
Erica Kollmann
RBC Capital Reiterates Outperform on Mind Med...
Benzinga Newsdesk
Shares of psychedelics companies are trading ...
Benzinga Newsdesk
DouYu International Posts Q1 Results, Joins Annexon, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
Why Stitch Fix Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, May 28, 2024
Baird Initiates Coverage On Mind Medicine wit...
Benzinga Newsdesk
Friday, May 24, 2024
HC Wainwright & Co. Reiterates Buy on Mind Me...
Benzinga Newsdesk
'Top Federal Drug Official Says There's 'Trem...
Benzinga Newsdesk
Saturday, May 18, 2024
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
Nicolás Jose Rodriguez
Wednesday, May 15, 2024
Jim Cramer: This Industrial Company Is 'Absolutely Terrific', Recommends Buying Modine Manufacturing
Avi Kapoor
Monday, May 13, 2024
Oppenheimer Reiterates Outperform on Mind Med...
Benzinga Newsdesk
Seritage Growth Properties Posts Q1 Loss, Joins Fortrea Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
Friday, May 10, 2024
HC Wainwright & Co. Maintains Buy on Mind Med...
Benzinga Newsdesk
Thursday, May 09, 2024
Mind Medicine Presents New Studies At ISPOR 2...
Benzinga Newsdesk
Wednesday, May 08, 2024
Mind Medicine Q1 2024 GAAP EPS $(1.14) Misses...
Benzinga Newsdesk
Tuesday, May 07, 2024
"FDA Expert Committee Will Review MDMA-Assist...
Benzinga Newsdesk
Monday, May 06, 2024
Reported Saturday, MindMed Unveils Phase 2b D...
Benzinga Newsdesk
Friday, April 19, 2024
Jim Cramer Slams Political Blocking Of 'LSD-Derived Antidepressants,' Citing Strong Test Data 'Showing They Worked'
Caleb Naysmith
Wednesday, April 17, 2024
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
Lara Goldstein
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
Lara Goldstein
Monday, April 15, 2024
Leerink Partners Initiates Coverage On Mind M...
Benzinga Newsdesk
Wednesday, April 10, 2024
Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Thursday, April 04, 2024
Simulations Plus Posts Upbeat, Joins Levi Strauss, BlackBerry And Other Big Stocks Moving Higher In Thursday's Pre-Market Session
Avi Kapoor
Monday, April 01, 2024
MindMed Reports Voluntary Delisting From Cboe...
Benzinga Newsdesk
Friday, March 29, 2024
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
Lara Goldstein
Wednesday, March 27, 2024
Podcast: LSD 'Deserves To Reclaim Its Spot At The Lead Of The Path For Psychedelics' Says MindMed's R. Barrow
Lara Goldstein
Wednesday, March 20, 2024
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
Lara Goldstein
Thursday, March 14, 2024
Reported Earlier, 'Indiana Lawmakers Send Psi...
Benzinga Newsdesk
Why Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
HC Wainwright & Co. Reiterates Buy on Mind Me...
Benzinga Newsdesk
Wednesday, March 13, 2024
Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement
Lara Goldstein
Show More